- Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program
2016) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 34(6). p.254.e7-254.e13 Mark(
- Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program
- A Belgian registry of interleukin-2 administration for treatment of metastatic renal cell cancer and confrontation with literature data
- Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.